Cohen Neil Harris
Director
SaleAlert
- Shares
- 1,000
- Price
- $2.80
- Value
- $2,800
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•11 filings
CMMB
Chemomab Therapeutics Ltd.
Net sales of $6.5K over the last 3 months
1 seller account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 2 CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$6,516
0 buyers · 1 sellers
12-month purchases
$20,246
1 distinct insiders
12-month sales
$6,516
1 distinct insiders
Highlighted alerts
4
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
2 executive purchases found
Get CMMB insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
CMMB overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
13
Raw transactions
Everything returned by the filing
4
Voluntary view
P/S trades after deterministic checks
7
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 5,172
- Price
- $0.00
- Footnotes
- 6
The options reported in this row were granted to the Reporting Person by the Issuer on July 16, 2020, and are fully vested and exercisable as of the date of this report. The options reported in this row were granted to the Reporting Person by the Issuer on April 19, 2021, and are fully vested and exercisable as of the date of this report. The options reported in this row were granted to the Reporting Person by the Issuer on March 7, 2022, and are fully vested and exercisable as of the date of this report. The options reported in this row were granted to the Reporting Person by the Issuer on March 21, 2023, and are fully vested and exercisable as of the date of this report. The options reported in this row were granted to the Reporting Person by the Issuer on March 18, 2024, and are fully vested and exercisable as of the date of this report. The options reported in this row were granted to the Reporting Person by the Issuer on March 16, 2025, and are fully vested and exercisable as of the date of this report.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Cohen Neil Harris
Director
SaleAlert
- Shares
- 1,304
- Price
- $2.85
- Value
- $3,716
Mor George Adi
Chief Executive Officer
PurchaseAlert
- Shares
- 4,926
- Price
- $2.08
- Value
- $10,246
Mor George Adi
Chief Executive Officer
PurchaseAlert
- Shares
- 4,878
- Price
- $2.05
- Value
- $10,000
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Aug 28, 2026 | Cohen Neil Harris Director | Sale | 1,000 | $2.80 | $2,800 | |
| Aug 27, 2026 | Cohen Neil Harris Director | Sale | 1,304 | $2.85 | $3,716 | |
| May 29, 2026 | Mor George Adi Chief Executive Officer | Purchase | 4,926 | $2.08 | $10,246 | |
| May 29, 2026 | Mor George Adi Chief Executive Officer | Purchase | 4,878 | $2.05 | $10,000 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.